Expression profiling of miR-96, miR-584 and miR-422a in colon cancer and their potential involvement in colon cancer pathogenesis
Abstract
Purpose: To determine the correlation between miRNAs; miR-96, miR-422a and miR584, and colon cancer, and also to test whether any of these miRNAs can act as non-invasive biomarkers in colon cancer
Methods: The tumor samples and the corresponding normal mucosa used in this study were collected from 60 patients diagnosed with colon cancer. HT-29, HCT-116 and SW-620 cell lines were used for miRNA expression profiling. Total RNA was extracted using kit-based methods with minor modifications, and specific miRNAs were detected and quantified by quantitative real-time polymerase chain reaction [RT-PCR].
Results: The results indicate down-regulation of miR-96, miR-584 and miR-422a in colon cancer tissue and decreased expression levels in the three colon cancer cell lines (all p < 0.01). Lower miRNA expression levels are correlated with increased tumor size.
Conclusion: This study shows that miR-96, miR-584 and miR-422a are down-regulated in colon cancer and are associated with tumor size. Thus, the ratio of miR-96/miR-638 in plasma is a potential noninvasive biomarker in colon cancer.
Keywords: Colon cancer, miR-96, miR-422a, miR-584, Expression profiling, Biomarker
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.